We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Perform Compliant USP 232 and ICH Q3D Elemental Analysis

Elemental impurities in pharmaceutical formulations can interfere with drug efficacy or have a toxic effect on the patient. Regulators have issued guidelines—such as ICH Q3D, USP 232 and USP 233 Elemental Impurities.

Download this application compendium to learn how to monitor a range of metal elemental impurities in pharmaceutical materials using elemental analysis techniques such as:

  • ICP-MS or,
  • AAS

As well as tips to ensure specific validation requirements described in the guidelines are met.